GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » argenx SE (WBO:ARGX) » Definitions » Cyclically Adjusted PS Ratio

argenx SE (WBO:ARGX) Cyclically Adjusted PS Ratio : 77.39 (As of Sep. 20, 2024)


View and export this data going back to 2020. Start your Free Trial

What is argenx SE Cyclically Adjusted PS Ratio?

As of today (2024-09-20), argenx SE's current share price is €477.50. argenx SE's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2024 was €6.17. argenx SE's Cyclically Adjusted PS Ratio for today is 77.39.

The historical rank and industry rank for argenx SE's Cyclically Adjusted PS Ratio or its related term are showing as below:

WBO:ARGX' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 65.12   Med: 110.69   Max: 151.79
Current: 80.15

During the past years, argenx SE's highest Cyclically Adjusted PS Ratio was 151.79. The lowest was 65.12. And the median was 110.69.

WBO:ARGX's Cyclically Adjusted PS Ratio is ranked worse than
94.83% of 464 companies
in the Biotechnology industry
Industry Median: 5.33 vs WBO:ARGX: 80.15

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

argenx SE's adjusted revenue per share data for the three months ended in Jun. 2024 was €7.459. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €6.17 for the trailing ten years ended in Jun. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


argenx SE Cyclically Adjusted PS Ratio Historical Data

The historical data trend for argenx SE's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

argenx SE Cyclically Adjusted PS Ratio Chart

argenx SE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 140.03 76.94

argenx SE Quarterly Data
Mar19 Jun19 Sep19 Dec19 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 109.85 120.41 76.94 70.63 67.92

Competitive Comparison of argenx SE's Cyclically Adjusted PS Ratio

For the Biotechnology subindustry, argenx SE's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


argenx SE's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, argenx SE's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where argenx SE's Cyclically Adjusted PS Ratio falls into.



argenx SE Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

argenx SE's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=477.50/6.17
=77.39

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

argenx SE's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2024 is calculated as:

For example, argenx SE's adjusted Revenue per Share data for the three months ended in Jun. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2024 (Change)*Current CPI (Jun. 2024)
=7.459/129.9100*129.9100
=7.459

Current CPI (Jun. 2024) = 129.9100.

argenx SE Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 0.022 99.390 0.029
201406 0.014 99.240 0.018
201409 0.099 99.960 0.129
201412 0.092 99.050 0.121
201503 0.077 99.750 0.100
201506 0.098 100.230 0.127
201509 0.146 100.500 0.189
201512 0.110 99.730 0.143
201603 0.143 100.310 0.185
201606 0.168 100.260 0.218
201609 0.245 100.570 0.316
201612 0.173 100.710 0.223
201703 0.256 101.440 0.328
201706 0.615 101.370 0.788
201709 0.240 102.030 0.306
201712 0.271 101.970 0.345
201803 0.172 102.470 0.218
201806 0.365 103.100 0.460
201809 0.058 103.950 0.072
201812 0.035 103.970 0.044
201903 0.913 105.370 1.126
201906 0.199 105.840 0.244
201909 0.183 106.700 0.223
201912 0.469 106.800 0.570
202006 0.000 107.510 0.000
202012 0.000 107.850 0.000
202103 2.660 108.870 3.174
202106 4.466 109.670 5.290
202109 0.014 110.790 0.016
202112 0.447 114.010 0.509
202203 0.408 119.460 0.444
202206 1.298 119.050 1.416
202209 2.524 126.890 2.584
202212 2.969 124.940 3.087
202303 3.684 124.720 3.837
202306 4.473 125.830 4.618
202309 5.316 127.160 5.431
202312 6.308 126.450 6.481
202403 6.220 128.580 6.284
202406 7.459 129.910 7.459

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


argenx SE  (WBO:ARGX) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


argenx SE Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of argenx SE's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


argenx SE Business Description

Industry
Address
Laarderhoogtweg 25, Amsterdam, NH, NLD, 1101EB
Argenx is a Dutch company focused on using its antibody engineering technology to treat rare autoimmune diseases. Vyvgart (efgartigimod) was approved in the U.S. in December 2021 as a treatment for generalized myasthenia gravis, followed by approvals in Europe and Japan in 2022.